AVANT BIO LLC strengthens its operational expertise by adding industry veterans Peggy Lio and Philip Vanek to its advisory team to accelerate commercialization efforts.
AVANT BIO announced the appointment of two operating advisors to support commercialization and growth, a neutral operational update with minimal market impact.
Growth equity firm AVANT BIO LLC has expanded its leadership bench by appointing Peggy Lio and Philip Vanek, Ph.D., as Operating Advisors. The new appointees will focus on supporting the firm's portfolio companies in commercialization and long-term growth strategies within the life science industrials sector.
AVANT BIO LLC is a growth equity firm that specializes in investments within the life science industrials and enabling technologies sectors.